The fourth edition of our X-omics festival “the future of multi-omics research is now!” will take place on Monday April 11th 2022 as a HYBRID event.
The event will include:
The X-omics festival 2022 will host poster sessions, both virtual (in Gather.Town) and in-person (at the conference venue). OMICS researchers can submit a poster abstract.
At the conference venue, the participants will have time to check out the posters and ask questions during the breaks of the festival. Your in person presence will be required during the breaks, to answer questions from participants.
Online, posters will be presented as a PDF in a virtual platform (Gather.Town) and participants will be able to video talk to you directly (1 on 1 or in small groups) to ask questions about your poster during the breaks of the festival.
Submitting your poster for both the online and in-person conference is one of the possibilities. Keep in mind that your in person presence will be required at the venue to answer questions from participants. Questions from online participants will need to be asked via chat and answered at a later moment.
The best poster will be rewarded with an award in the closure session of the X-omics festival!
Please submit an abstract in Word format, using max 500 words, including:
For online display
For display at the in-person event
You are supposed to bring the printed version of the poster with you, size A0.
Alain van Gool is professor Personalized Healthcare and heads the Translational Metabolic Laboratory at the Radboud university medical center, with a strong passion in the application of biomarkers in translational medicine and personalized healthcare. After his study (biochemistry, 1991) and PhD (molecular biology, 1996) Alain worked at a mix of academia, pharmaceutical industries, applied research institutes, university medical centers in Europe, Asia and USA. He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. His technical expertise resides most strongly in molecular profiling (various Omics approaches), analytical biomarker development and applications in translational scientific research.
Alain is a strong believer of open innovation networks and thrives to work with specialists to translate basic research to applied science. With that background, he currently also acts as Strategic Advisor to the Executive Board of Radboudumc, co-coordinates the Radboudumc Technology Centers, is Scientific Lead Technologies of DTL (the Dutch Techcenter for Life Sciences), is Chair Biomarker Platform of EATRIS (the European infrastructure for Translational Medicine), is co-initiator of Health-RI (the Netherlands Health Research Infrastructure for Personalized Medicine and Health), and project leader and PI of the Netherlands X-omics Initiative, thus contributing to the organisation and coordination of local, national and European technology infrastructures. Complementing his daily work, he enjoys contributing to scientific advisory boards of start-up enterpreneurs, multinational companies, translational organisations, funding agencies and conference organisers.
Prof. Dr. Ron M.A. Heeren obtained a PhD degree in technical physics in 1992 at the University of Amsterdam on plasma-surface interactions. He was the research group leader at FOM-AMOLF for macromolecular ion physics and biomolecular imaging mass spectrometry in the period 1995-2015. In 2001 he was appointed professor at the chemistry faculty of Utrecht University lecturing on the physical aspects of biomolecular mass spectrometry and later became part of the Netherlands Proteomics Center. In 2014 he was appointed as distinguished professor and Limburg Chair at Maastricht University. He is scientific director of M4I, the Maastricht MultiModal Molecular Imaging institute on the Brightlands Maastricht Health campus. There, he heads the division of imaging MS. Currently he serves as the chair of the NWO research community “advanced methods, instrumentation and data analysis” for the life sciences. He was awarded the prestigious 2019 Physics Valorization prize by the Dutch organization for scientific Research, NWO and the 2020 Thomson medal of the international mass spectrometry foundation. In 2021 he was elected as a member of the Royal Dutch Academy of Sciences, KNAW. His academic research interests are mass spectrometry based personalized medicine, translational molecular imaging and “omics” research, high-throughput bioinformatics and the development and validation of new mass spectrometry based molecular imaging techniques for the life sciences. He is actively involved in the development of molecular imaging education, instrumentation engineering and the improvement of the Dutch national large scale research infrastructure.
Jenny van Dongen is an assistant professor at the Netherlands Twin Register, department of Biological Psychology, VU Amsterdam. She obtained a bachelor’s degree in biology and a master’s degree in neuroscience at the Vrije Universiteit Amsterdam and did her PhD on twin-family analyses of metabolic syndrome traits and epigenetic profiles at the Vrije Universiteit Amsterdam in close collaboration with the Leiden University Medical Center. Dr. van Dongen is renowned for her work on epigenetic analyses of twins. She created a catalogue of the heritability of DNA methylation levels across the genome. Together with an international team of twin researchers, she recently discovered that identical (monozygotic) twins carry a stable DNA methylation signature of the twinning event in adult somatic tissues, which represented a breakthrough for our understanding of the biology of identical twinning.